NCPL Q1 2026 Earnings Significant EPS Miss Amid Sharp Stock Rally Oracle ORCL Gains Wedbush Price Target Hike as Analysts Point to Overlooked Demand Visibility TRNR Q4 2025 Earnings Deep EPS Miss Highlights Ongoing Struggles AURA Q1 2026 Earnings EPS Misses Estimates Stock Rises 24 on PreClinical Progress Acumen Pharmaceuticals Q1 2026 Earnings Narrowed Loss Surprises as Alzheimers Pipeline Advances NVST Q1 2026 Earnings EPS Beats Estimates by Nearly 13 as Stock Slips KOSS Q1 2026 Earnings Navigating a Transitional Period as Focus Shifts to Brand Reinvention